Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Aymin Delgado

Pediatric Gastroenterology Naples, FL Medical Doctor

NPI 1124098538 CMS profile 96717

2600 Immokalee Rd, Naples, FL 34110

Open in the dashboard

General payments

$44,645

269 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$69,247 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Aymin Delgado of Naples, FL is reported in the CMS Open Payments database as having received $44,645 across 269 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $69,247 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,227 55
2024 General $10,184 51
2023 General $13,566 43
2022 General $1,506 19
2021 General $492 24
2020 General $654 36
2019 General $13,016 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aymin Delgado
  • Pediatric Gastroenterology median
  • Middle half of Pediatric Gastroenterology
  • National median

In program year 2025, general payments to Aymin Delgado were reported at $5,227. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.

Show as a table
Year Aymin Delgado Pediatric Gastroenterology median Middle half National median
2019 $13,016 $131 $41–$311 $163
2020 $654 $79 $23–$223 $114
2021 $492 $104 $32–$321 $132
2022 $1,506 $125 $37–$331 $149
2023 $13,566 $169 $55–$440 $160
2024 $10,184 $196 $73–$563 $164
2025 $5,227 $194 $81–$540 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mirum Pharmaceuticals, Inc. $14,774 33 payments
  2. Alexion Pharmaceuticals, Inc. $13,708 22 payments
  3. Albireo Pharma, Inc. $8,118 5 payments
  4. Ipsen Biopharmaceuticals, Inc $4,230 33 payments
  5. QOL Medical, LLC $788 55 payments
  6. Janssen Biotech, Inc. $674 27 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $493 18 payments
  8. Genzyme Corporation $473 19 payments
  9. AbbVie, Inc. $414 18 payments
  10. Retrophin, Inc. $262 16 payments
  11. Other $711 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $17,433 6 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,300 5 payments
  3. Travel and Lodging $7,028 15 payments
  4. Food and Beverage $6,712 234 payments
  5. Education $172 9 payments
Products named General payments · program years 2019–2025
  1. Livmarli $14,774 33 payments
  2. Bylvay $12,202 36 payments
  3. Strensiq $4,788 5 payments
  4. Kanuma $805 6 payments
  5. STELARA $744 26 payments
  6. DUPIXENT $473 19 payments
  7. Sucraid Therapy For Csid $418 34 payments
  8. HUMIRA $385 17 payments
  9. GATTEX $342 11 payments
  10. Sucraid Therapy For Csid $278 16 payments
  11. Other $1,526 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

269 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Gastroenterology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record